Question 1

Does Bank of New York Mellon own SAVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Bank of New York Mellon holds 20,284 shares of SAVA (Filana Therapeutics), worth $24,138.

Question 2

How many shares of SAVA does Bank of New York Mellon own?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon holds 20,284 shares of SAVA (Filana Therapeutics).

Question 3

What is Bank of New York Mellon's SAVA position worth?

Accepted Answer

As of its Q2 2026 13F, Bank of New York Mellon's SAVA position is worth $24,138.

Question 4

Is Bank of New York Mellon buying or selling SAVA?

Accepted Answer

In Q2 2026, Bank of New York Mellon reduced its SAVA position by 197 shares (-1.0%).

Question 5

When did Bank of New York Mellon first buy SAVA?

Accepted Answer

Bank of New York Mellon already held SAVA in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	20,284	-1.0%	$24,138	0.0%	$1.19	0
2026-Q1	Unchanged	20,481	0.0%	$34,613	0.0%	$1.69	0
2025-Q4	Increased	20,481	+92.1%	$40,552	0.0%	$1.98	22
2025-Q3	Unchanged	10,663	0.0%	$31,028	0.0%	$2.91	0
2025-Q2	Decreased	10,663	-90.4%	$19,299	0.0%	$1.81	0
2025-Q1	Decreased	110,658	-0.1%	$165,987	0.0%	$1.50	0
2024-Q4	Increased	110,794	+2.7%	$261,474	0.0%	$2.36	16
2024-Q3	Decreased	107,842	-23.4%	$3.2M	0.0%	$29.43	0